CPT Code 43239: Complete Guide to EGD with Biopsy

Leave out one element of CPT code 43239, and your claim will be rejected even though the procedure is performed flawlessly. This single code makes up a big chunk of all gastroenterology coding and billing; however, it is also one of the least understood codes. In our guide, we have broken down every aspect of the code, including: Code Description, Procedure Details, Billing Guidelines, Documentation Must-Haves, Modifiers, and the common errors that can trap an experienced coder.

What Is CPT Code 43239?

CPT Code 43239 is defined as an Upper GI Endoscopy (EGD). This can include one or more Biopsies in addition to viewing the Esophagus, stomach, and/or Duodenum. It may be utilized when a Physician completes a Diagnostic EGD; however, at some point, the physician will collect Tissue Samples for additional testing. The main difference between this and CPT 43235 (Diagnostic EGD without biopsy) would be if the physician collected no tissue during the procedure.

What Does EGD Mean?

EGD is an abbreviation for “Esophagogastroduodenoscopy,” a technique used by doctors to see inside the upper gastrointestinal (GI) tract. 
The upper GI system includes the esophagus, stomach, and duodenum; therefore, during an EGD exam, your doctor can visually evaluate each organ individually. 
Because it provides such thorough evaluation of the upper GI system, EGD is also considered one of the most important diagnostic techniques available today.

What Is an EGD with Biopsy?

An EGD with biopsy is an upper endoscopy procedure where the physician not only examines the esophagus, stomach, and duodenum but also removes small tissue samples for lab analysis. These biopsies help diagnose conditions such as ulcers, infections (including H. pylori), inflammation, and abnormal cell changes, including cancer. Unlike a standard diagnostic EGD, this version confirms findings at a cellular level rather than relying on visual inspection alone.

Purpose of the Procedure

An EGD with biopsy can help your physician determine why you have been experiencing an unusual number of upper GI problems that include: chronic (persistent) heartburn, pain for which no cause has been identified, or difficulty in swallowing. The physician is able to identify the presence of several diseases/conditions, including peptic ulcers, gastritis, celiac disease, Barrett’s esophagus, and even early stages of cancers by examining the area visually and obtaining samples from the biopsied tissues. Combining visual inspection with tissue sample collection will typically provide a physician with a more definitive diagnosis than would be provided through either an imaging study or a review of your patient history.

When a Biopsy Is Necessary?

The decision to perform a biopsy is usually made when an abnormal area of tissue (such as inflammation, ulcers, or lesions) is seen by the doctor on an upper GI endoscopy (EGD). 
Biopsy may be suggested in patients at high-risk for conditions such as H. pylori infection, celiac disease, or Barrett’s esophagus. In addition, physicians will sometimes take biopsies out of caution based upon the presence of ongoing or unclear gastrointestinal symptoms.

Common Medical Conditions That Require CPT 43239

CPT 43239 is most often used in billing for chronic gastroesophageal reflux (GERD), unexplained abdominal pain, chronic dysphagia, peptic ulcers, and gastritis. 
Additionally, this code can be used when testing for Helicobacter pylori infections, celiac disease, Barrett’s esophagus, and Eosinophilic Esophagitis. 
The procedure may help eliminate a cause of unexplained weight loss as well as rule-in/rule-out malignant conditions causing anemia.

1. Gastroesophageal Reflux Disease (GERD)

EGD (Endoscopy) with a biopsy can confirm whether you have GERD (Gastroesophageal Reflux Disease), and if so, how much damage to your Esophagus has occurred due to the consistent presence of stomach acid. A biopsy will also allow for an examination to see if there are other issues present, such as Barrett’s esophagus, stricture, or other damage resulting from years of chronic heartburn.
The physician is able to determine the extent of the damage that the patient’s esophagus has experienced through a biopsy, which allows them to go past just visually inspecting the inside of the esophagus.

2. Barrett’s Esophagus

Barrett’s esophagus occurs because of chronic acid reflux that causes an alteration in the lining of your esophagus, which increases your cancer risk.
Only a biopsy can verify that you have these cell changes since the condition cannot be identified by visual examination alone.
EGD (upper endoscopy) with biopsy may also need to be performed regularly to look for pre-cancerous progression in individuals who are diagnosed.


3. Gastritis

Gastritis is inflammation of the stomach lining. Gastritis can be caused by an infection, a reaction to medication, or drinking too much alcohol.
The biopsy will confirm your diagnosis and help us figure out what’s causing it (like H. pylori). It also lets doctors know whether you have gastritis or something else that could look like it.

4. Peptic Ulcers

Ulcers of the peptic type are open wounds that occur in the mucosa of the stomach or duodenum, which can lead to painful episodes of gastrointestinal hemorrhage.
Biopsy samples taken during endoscopy (EGD) assist in distinguishing between ulcers created by infections with H. pylori and those that may be malignant in nature.
A determination of this type will also influence the choice of therapy for the patient.


5. Celiac Disease


Celiac Disease is a chronic Autoimmune disorder that results from the ingestion of Gluten (wheat), leading to mucosal inflammation and damage to the Lining of the Small Intestine.
The Duodenal Biopsy is considered the “Gold Standard” for diagnosing Celiac Disease because it demonstrates the typical Histological Changes associated with the disease.
Therefore, Endoscopy with a biopsy is mandatory for Accurate Diagnosis of Celiac Disease when it is suspected.


6. Unexplained Upper GI Bleeding

Endoscopy (EGD) with biopsy is an important diagnostic tool in identifying patients who have experienced unexplained upper gastrointestinal bleeding. It identifies the source of bleeding and provides information about what caused it to occur. 
The results from an endoscopic examination may include findings such as ulcers, tumor growth, inflammatory conditions, and/or vascular abnormalities that are causing the patient’s upper GI bleeding. 
Biopsy samples will then determine if these findings are either benign or require immediate treatment.


7. Esophageal or Gastric Tumors

Tumors within the esophagus or stomach are primarily diagnosed via EGD (Endoscopy) along with biopsy.
The pathology of the biopsied tissue will help identify if a tumor is benign, pre-cancerous, or cancerous.
Early identification through biopsy allows for earlier treatment planning, which has been shown to improve patients’ quality of life.

What Is Included in CPT Code 43239?

The entire EGD process, including the scope being inserted to look at the esophagus, stomach, and duodenum with biopsy samples, will be included in CPT 43239. CPT 43239 does not matter how many biopsy samples were obtained. The service will be coded one time for each endoscopy. All related services such as moderate sedation when appropriate or routine post-procedure observation will also be included in this code.

CPT 43239 Billing Guidelines

Regardless of how many specimens are collected, CPT 43239 is coded one time for each session as this is not a specimen-specific code. Additional codes may be required if other separate services such as dilation or polypectomy were completed during the same session. The coder should reference the applicable NCCI and payers’ guidelines as they may have different documentation requirements in addition to the potential for bundling edits.

Common Modifiers Used with CPT Code 43239

Modifying billing for CPT 43239 in combination with another procedure or under an exception allows a provider to bill accurately. Some of these modifiers are 59 (a distinct procedural service), 76/77 (the same/different doctor performed this repeat procedure), 22 (an increased procedural service), as needed. Properly modifying claims avoids denied claims and clarifies to a payer why you have two services or an exception on your session.

Modifier 25

The use of Modifier 25 allows for an additional charge for a separate service (E/M) provided at the time of the EGD procedure. 
This is because there is a need to show that both the office visit and the decision to have the procedure were separate. 
Modifier 25 should never be used unless there are clear billing records supporting two completely different services being billed.

Modifier 59

Modifier 59 identifies a distinct procedural service when CPT 43239 is billed alongside another procedure that might otherwise be bundled.
It signals to payers that the two procedures were performed on different sites, sessions, or lesions.
Misuse of this modifier is a common audit trigger, so documentation must clearly justify its use.

Modifier XS

Modifier XS is a more specific alternative to modifier 59 and is used to indicate separate structures or organ sites.
Payers prefer XS because it demands greater specificity than what modifier 59 offers. Using XS instead of 59 tends to reduce claims that are denied when there is a difference in anatomical site.

When Modifiers Should Not Be Used

Modifiers should not be applied simply to bypass bundling edits or increase reimbursement without clinical justification.
They should never be used when the services performed are inherently part of the same procedure.
Inappropriate modifier use is a major compliance risk and a common target during payer audits.

Common Coding and Billing Errors

A common coding mistake occurs when one submits CPT 43239 multiple times for a single patient visit with biopsy sites; however, this is only allowed to be billed once.
The most common errors in coding are the use of CPT 43239 alone, while performing a therapeutic procedure during the same session, including but not limited to polyps removed or bleeding controlled, and failure to apply an appropriate add on code or modifier.
The two other leading causes of claim denial and audit flags due to insufficient documentation are lack of adequate documentation for the biopsies performed and/or failure to include biopsy locations.

Billing Diagnostic EGD Separately

Some developers incorrectly charge for CPT 43235 (Diagnostic Esophagogastroduodenoscopy), in addition to CPT 43239, for the same procedure.
Billing for both codes will be considered double billing of services because CPT 43239 includes the Diagnostic Component.
CPT 43239 should be billed alone if an endoscopic biopsy was taken during the diagnostic esophagogastroduodenoscopy.

Reporting Multiple Units

A common error is billing multiple units for CPT 43239 when biopsies are taken from several sites in a single session.
Regardless of how many biopsy locations are involved, the code should be reported only once. This mistake often leads to claim denials or payment recoupment during audits.


Missing Biopsy Documentation

Failure to include explicit documentation that a biopsy was completed can be a primary cause for denials/downcoding of claims.
Procedure notes that do not clearly detail the “collection of tissue,” but instead use vague terms such as “visualization,” will fail to provide sufficient justification for using CPT 43239 versus an alternative, purely diagnostic code.

Incorrect Modifier Usage

Modifiers such as 59 (or XS) are frequently used without an appropriate clinical basis in an attempt to avoid bundling edits without documentation to support this decision. 
This can be the cause of improper coding that may result in auditor claims due to audit by payers and claim reversal.

Incomplete Procedure Notes

Procedure notes with insufficient detail about biopsy site(s), number of sample(s) submitted for pathology testing, etc., will adversely affect the strength of your supporting documentation.
Insufficient documentation in the procedure note may also limit verification of medical necessity and/or the correct selection of the procedure code.
Complete and detailed documentation is vital to avoiding denied claims and ensuring compliance when submitting bills.

Best Practices for Accurate Coding

To avoid denied claims and “bundled” claims due to inaccurate application of modifiers, keep up-to-date on each specific payer’s guidelines, NCCI edits, and required modifiers. Regularly perform chart reviews, and provide continuing education/training to coders in order to detect documentation deficiencies as soon as possible so that you may continue to apply consistently compliant billing practices.

1. Verify Clinical Documentation

Always verify that your procedure notes indicate clearly that a biopsy has been performed (i.e., include location/site of biopsy, type/sample of tissue), etc. Documentation deficiencies/inadequate documentation is usually the reason for denial of most claims. Checking notes prior to submitting will assist in ensuring the accurate/compliant use of coding.

2. Follow CPT Guidelines

Keep current on all updates from the official CPT coding guidelines in order to code CPT 43239 accurately. This involves knowing about bundling rules and what separates individual procedures into different codes. Keeping current with updates lessens the number of errors and associated audit risk.

3. Ensure Accurate Diagnosis Coding

Apply the proper ICD-10 diagnosis codes along with CPT 43239 to validate medical necessity. 

Claims may be rejected/delayed if the coded diagnoses do not match/correlate. The application of accurate diagnostic codes supports the overall validity of your claim.

4. Conduct Regular Coding Audits

Auditing your coding process on a routine basis will allow you to identify areas where there is potential for documentation deficiencies, coding errors, or modifier misapplication prior to submission. Auditing ensures continuous compliance with changing payer/CMS regulations. Routine auditing will ultimately lower your claim denial rate and improve long-term billing accuracy.

Conclusion

Flexible Transoral Upper GI Endoscopy with Biopsy (CPT Code 43239) is an important diagnostic tool for identifying many upper gastrointestinal diseases, including GERD (Gastroesophageal Reflux Disease), peptic ulcer disease, and Barrett’s Esophagus. The importance of good documentation and the proper use of codes and billing procedures cannot be overstated, as they directly relate to reducing denied claims and receiving appropriate payment.